Search details
1.
Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
Radiology
; 299(3): 613-623, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33847515
2.
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy.
J Urol
; 205(2): 420-425, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32945736
3.
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
J Transl Med
; 18(1): 10, 2020 01 07.
Article
in English
| MEDLINE | ID: mdl-31910880
4.
Impact of Subsequent Biopsies on Comprehensive Health Related Quality of Life in Patients with and without Prostate Cancer.
J Urol
; 201(5): 916-922, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30676475
5.
A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.
Can J Urol
; 26(4): 9809-9820, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31469635
6.
Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
Int J Mol Sci
; 20(19)2019 Oct 02.
Article
in English
| MEDLINE | ID: mdl-31581661
7.
Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
Cancer
; 123(21): 4252-4258, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28678408
8.
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer.
J Urol
; 196(2): 392-8, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26976206
9.
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
Cancer
; 121(14): 2465-73, 2015 Jul 15.
Article
in English
| MEDLINE | ID: mdl-25845467
10.
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.
Sci Rep
; 12(1): 5404, 2022 03 30.
Article
in English
| MEDLINE | ID: mdl-35354846
11.
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.
Cancer Med
; 11(22): 4354-4365, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35638719
12.
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.
Nat Commun
; 13(1): 1361, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-35292633
13.
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017.
Cancer Med
; 11(24): 4756-4766, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35616266
14.
Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: A Case report.
Urol Case Rep
; 39: 101780, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34345592
15.
Prognostic features of Annexin A2 expression in prostate cancer.
Pathology
; 53(2): 205-213, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32967771
16.
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.
Sci Rep
; 11(1): 15052, 2021 07 23.
Article
in English
| MEDLINE | ID: mdl-34302010
17.
Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer.
Oncotarget
; 11(15): 1321-1333, 2020 Apr 14.
Article
in English
| MEDLINE | ID: mdl-32341752
18.
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.
Urol Oncol
; 38(10): 794.e1-794.e9, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32139288
19.
Race, tumor location, and disease progression among low-risk prostate cancer patients.
Cancer Med
; 9(6): 2235-2242, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31965751
20.
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.
Cancers (Basel)
; 12(5)2020 May 17.
Article
in English
| MEDLINE | ID: mdl-32429558